Coris BioConcept - in close collaboration with;
The University Hospital Laboratory of Brussels, the Karolinska Institute in Stockholm, the University of Milan and the Institute of Virology in Leipzig and the support of the National Reference Centre for Respiratory Pathogens as well as the laboratory of the University Hospital of Liège
- has developed a rapid diagnostic test making it possible to detect the SARS-COV-2 virus in patients with severe infection.
The product gives results in 15 minutes
COVID-19 Ag Respi-Strip detects the presence of SARS-Cov-2 antigens in a nasopharyngeal swab in 15 minutes in more than 7 out of 10 patients with the high viral load (Ct <25*) found in the acute phase of covid-19.
An algorithm is proposed whereby patients are screened with Ag Respi-Strip. Decisions concerning isolation and cohorting can be made on positive results, negative results are submitted for qPCR.
This test is CE marked and will be an excellent complement to the molecular biology screening methods currently used in hospitals. A paper covering the development and clinical performance of the Ag Respi-Strip assay has been submitted for publication.
Ag-Respi Strip is CE marked.